Abbott Molecular, Inc. recalls Alinity m Resp-4-Plex Amplification (AMP) Kit (CE)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- There were reports of an increase in reactive negative controls and false positive results.
- Products
-
- Alinity m Resp-4-Plex Amplification (AMP) Kit (CE)
- Company
- Abbott Molecular, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution.
Nationwide
- Barcodes
00884999049338- Units affected
- 1447 units
- About this recall
- Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the qualitative detection and differentiation of RNA from influenza A virus (flu A), influenza B virus (flu B), Respiratory Syncytial Virus (RSV), and SARS-CoV-2 in nasopharyngeal (NP) swab specimens collected by a healthcare provider, from individuals with signs and symptoms of respiratory tract infection